-
FDA Consumer Magazine: Prescription Drug News and Information, And More
Offers Broad Coverage, Including Reports On Current FDA Regulatory Activites FDA Consumer magazine is available online at no cost, while the traditional paper version of this federal government publication has a $14 annual subscription…
-
Many “Canadian” Online Drugs Are, In Fact, Not From Canada
FDA Says These Are "Drugs Of Dubious Origin, Safety, And Efficacy" In mid-December 2005 the FDA reported that the majority of Web sites believed to be Canadian pharmacies selling prescription drugs manufactured in Canada…
-
WHI Study Was Perhaps Flawed And Subsequent HRT Advice May Be Wrong
Cyclical Hormones, But Not Prempro, May Be Protective Against Heart Disease Many people will recall that in July 2002 women were told to talk to their doctor about perhaps stopping their hormone replacement therapy…
-
Bextra Will Not Return In Canada As Safety Risks Outweigh Benefits
Health Canada Safety Panel Cites Heart Attacks, Strokes, and Severe Skin Reactions Bextra, Pfizer’s anti-inflammatory drug for arthritis patients, will not be returned to the Canadian market according to a Health Canada announcement in…
-
FDA’s David Graham Says U.S. Drug Safety System No Better in 2005
Graham Criticizes Agency’s Performance During The Year Since Vioxx Recall In November 2004 David Graham, associate director for science and medicine at the FDA’s Office of Drug Safety, criticized the FDA’s drug oversight practices…
-
Large Study to Investigate Heart Risks Of Celebrex, Ibuprofen, and Naproxen
Cleveland Clinic’s Dr. Nissen To Lead 20,000 Patient "Precision" Clinical Trial In mid-December 2005 the drug company Pfizer Inc. announced that Dr. Steven E. Nissen, medical director of the Cleveland Clinic’s cardiovascular coordinating center,…